Cynapsus Therapeutics (CYNA) Vaulted To A New High After Merger Agreement

Cynapsus Therapeutics (CYNA) announced Thursday morning that it has agreed to be acquired by Sunovion Pharmaceuticals Inc. for US$40.50 per share in cash, approximately US$624 million.

from RTT - Before the Bell http://ift.tt/2bVqRrR
via IFTTT